Understanding Chickenpox in the Eye: What Every Patient Needs to Know

May 9, 2024

Back
Featured image for “Understanding Chickenpox in the Eye: What Every Patient Needs to Know”

Chickenpox is a highly contagious viral infection caused by the varicella-zoster virus (VZV). While it is most commonly associated with the characteristic itchy rash and blisters that appear on the skin, chickenpox can also affect other parts of the body, including the eyes. As a medical professional, it is crucial to educate patients about the potential ocular complications of chickenpox and provide guidance on prevention, diagnosis, and treatment.

In this comprehensive article, we will delve into the various aspects of chickenpox in the eye, discussing the symptoms, risk factors, and management strategies. By the end of this piece, patients will have a better understanding of how chickenpox can impact eye health and what steps they can take to protect their vision.

What is Chickenpox?

Chickenpox is a viral illness that primarily affects children but can occur in adults who have not been previously infected or vaccinated. The varicella-zoster virus, which causes chickenpox, is transmitted through direct contact with the fluid from chickenpox blisters or through airborne droplets when an infected person coughs or sneezes[1].

The classic symptoms of chickenpox include:

  • Fever
  • Fatigue
  • Loss of appetite
  • Headache
  • Itchy, red rash that progresses to fluid-filled blisters

While chickenpox is generally a mild illness in children, it can lead to more severe complications in adults, including pneumonia, encephalitis, and ocular issues[2].

How Chickenpox Affects the Eyes

When the varicella-zoster virus spreads to the eyes, it can cause a range of ocular complications, collectively known as chickenpox in the eye. These complications can occur during the initial chickenpox infection or later in life due to a reactivation of the virus, known as shingles.

The most common ocular manifestations of chickenpox include:

  1. Conjunctivitis: Inflammation of the conjunctiva, the thin, clear tissue that covers the white part of the eye and inner eyelid[3].
  2. Keratitis: Inflammation of the cornea, the clear, dome-shaped surface that covers the front of the eye[4].
  3. Uveitis: Inflammation of the uvea, the middle layer of the eye that includes the iris, ciliary body, and choroid[5].
  4. Retinitis: Inflammation of the retina, the light-sensitive tissue at the back of the eye responsible for vision[6].

These conditions can cause various symptoms, such as:

  • Red, irritated eyes
  • Eye pain or discomfort
  • Blurred or decreased vision
  • Sensitivity to light
  • Excessive tearing
  • Eyelid swelling or drooping

If left untreated, ocular complications of chickenpox can lead to permanent vision loss or blindness. Therefore, it is essential for patients to be aware of the potential eye-related issues associated with chickenpox and seek prompt medical attention if they experience any concerning symptoms.

Risk Factors for Ocular Complications

While anyone who contracts chickenpox is at risk of developing ocular complications, certain factors can increase an individual’s susceptibility:

  1. Age: Adults are more likely to experience severe chickenpox symptoms and complications, including eye-related issues[7].
  2. Immunocompromised status: Patients with weakened immune systems due to conditions like HIV/AIDS, cancer, or immunosuppressive medications are at a higher risk of developing ocular complications from chickenpox[8].
  3. Delayed or lack of treatment: Failing to seek prompt medical attention or not following the prescribed treatment plan can increase the likelihood of ocular complications[9].
  4. Exposure to infected individuals: Close contact with someone who has active chickenpox or shingles lesions near the eyes can increase the risk of ocular complications[10].

Patients who fall into any of these high-risk categories should be extra vigilant about monitoring their eye health during and after a chickenpox infection. They should also discuss their increased risk with their healthcare provider to ensure appropriate preventive measures and prompt treatment if necessary.

Diagnosing Chickenpox in the Eye

Diagnosing chickenpox in the eye involves a combination of clinical examination, patient history, and laboratory tests. When a patient presents with ocular symptoms suggestive of chickenpox, the healthcare provider will:

  1. Take a detailed medical history: The provider will ask about the patient’s recent exposure to chickenpox or shingles, as well as any history of chickenpox infection or vaccination.
  2. Perform a comprehensive eye exam: This may include visual acuity tests, slit-lamp examination, and fundoscopy to assess the extent and location of ocular inflammation and damage.
  3. Obtain laboratory tests: Viral cultures, polymerase chain reaction (PCR) tests, or blood tests for varicella-zoster virus antibodies can help confirm the diagnosis[11].

In some cases, the healthcare provider may also recommend imaging studies, such as optical coherence tomography (OCT) or fluorescein angiography, to evaluate the retina and detect any signs of retinal inflammation or damage[12].

Prompt and accurate diagnosis is crucial for initiating appropriate treatment and preventing long-term ocular complications. Patients should not hesitate to seek medical attention if they experience any eye-related symptoms during or after a chickenpox infection.

Treatment Options for Chickenpox in the Eye

The treatment for chickenpox in the eye depends on the specific ocular complication and its severity. In general, the goals of treatment are to:

  • Reduce inflammation
  • Alleviate symptoms
  • Prevent vision loss or permanent eye damage

Common treatment options include:

  1. Antiviral medications: Oral or intravenous antiviral drugs, such as acyclovir or valacyclovir, can help control the viral infection and reduce the duration and severity of ocular symptoms[13].
  2. Topical corticosteroids: Eye drops or ointments containing corticosteroids can help reduce inflammation in the eye and prevent scarring or vision loss[14].
  3. Cycloplegic agents: These medications temporarily paralyze the ciliary muscle in the eye, relieving pain and preventing the formation of posterior synechiae (adhesions between the iris and lens)[15].
  4. Lubricating eye drops: Artificial tears can help alleviate dryness and discomfort associated with ocular inflammation.
  5. Antibiotics: If a secondary bacterial infection develops, antibiotics may be prescribed to prevent further complications.

In severe cases or when there is a risk of permanent vision loss, the healthcare provider may recommend more aggressive treatments, such as:

  • Intravitreal antiviral injections
  • Systemic corticosteroids
  • Immunosuppressive medications

Patients must adhere to the prescribed treatment plan and attend regular follow-up appointments to monitor their eye health and adjust the treatment as needed.

Preventing Chickenpox and its Ocular Complications

The most effective way to prevent chickenpox in the eye is to avoid contracting the varicella-zoster virus in the first place. This can be achieved through vaccination and practicing good hygiene.

Vaccination

The varicella vaccine, which is part of the routine childhood immunization schedule, is highly effective in preventing chickenpox[16]. The vaccine is typically administered in two doses:

  • First dose: 12-15 months of age
  • Second dose: 4-6 years of age

Adults who have never had chickenpox or received the vaccine should consider getting vaccinated, especially if they are at high risk of exposure or complications. The adult vaccine schedule consists of two doses administered 4-8 weeks apart[17].

Hygiene Measures

In addition to vaccination, practicing good hygiene can help reduce the risk of contracting or spreading the varicella-zoster virus:

  • Wash hands frequently with soap and water, especially after contact with an infected person or contaminated surfaces.
  • Avoid close contact with individuals who have active chickenpox or shingles lesions.
  • Cover the mouth and nose when coughing or sneezing to prevent the spread of respiratory droplets.
  • Disinfect frequently touched surfaces and shared items.

Patients who have been exposed to chickenpox or develop symptoms should stay home and avoid contact with others until the rash has crusted over to prevent spreading the virus.

Chickenpox in the Eye: Specific Conditions and Their Management

Now that we have covered the general aspects of chickenpox in the eye, let’s take a closer look at some specific ocular conditions associated with the varicella-zoster virus and their management strategies.

Conjunctivitis

Chickenpox can cause inflammation of the conjunctiva, leading to symptoms such as redness, itching, tearing, and discharge. In most cases, chickenpox-related conjunctivitis is self-limiting and resolves without complications[18].

Management:

  • Apply cool compresses to the affected eye(s) to relieve discomfort.
  • Use lubricating eye drops to alleviate dryness and irritation.
  • Avoid rubbing the eyes to prevent further irritation and the spread of infection.
  • If a secondary bacterial infection is suspected, the healthcare provider may prescribe antibiotic eye drops or ointments.

Keratitis

Keratitis, or inflammation of the cornea, can occur when the varicella-zoster virus directly invades the corneal tissue or as a result of an immune-mediated response. Symptoms may include pain, blurred vision, sensitivity to light, and a sensation of a foreign body in the eye[19].

Management:

  • Antiviral medications, such as acyclovir or valacyclovir, to control the viral infection.
  • Topical corticosteroids to reduce inflammation and prevent scarring.
  • Cycloplegic agents to relieve pain and prevent posterior synechiae formation.
  • Lubricating eye drops to maintain corneal moisture and promote healing.
  • In severe cases, corneal transplantation may be necessary to restore vision.

Uveitis

Uveitis, or inflammation of the uvea, can manifest as anterior uveitis (affecting the iris and ciliary body) or posterior uveitis (affecting the choroid). Symptoms may include eye pain, redness, blurred vision, and floaters[20].

Management:

  • Topical corticosteroids to reduce inflammation in the anterior segment of the eye.
  • Systemic corticosteroids or immunosuppressive medications for severe or posterior uveitis.
  • Cycloplegic agents to relieve pain and prevent posterior synechiae formation.
  • Antiviral medications to control the underlying viral infection.
  • Regular monitoring for complications, such as glaucoma or cataract formation.

Retinitis

Retinitis, or inflammation of the retina, is a rare but serious complication of chickenpox that can lead to permanent vision loss if not promptly treated. Symptoms may include blurred or decreased vision, floaters, and blind spots[21].

Management:

  • Systemic antiviral medications, such as intravenous acyclovir, to control the viral infection.
  • Intravitreal antiviral injections to deliver high concentrations of medication directly to the affected eye.
  • Systemic corticosteroids to reduce inflammation and prevent retinal damage.
  • Close monitoring for complications, such as retinal detachment or neovascularization.
  • In severe cases, surgical intervention may be necessary to repair retinal damage or prevent further vision loss.

Patients with any of these ocular conditions should work closely with their healthcare provider to develop an individualized treatment plan and attend regular follow-up appointments to monitor their eye health.

Long-Term Complications and Follow-Up Care

Even after the acute phase of chickenpox in the eye has resolved, patients may be at risk of developing long-term complications. These can include:

  • Recurrent inflammation (e.g., uveitis or keratitis)
  • Corneal scarring or thinning
  • Glaucoma
  • Cataract formation
  • Retinal detachment or scarring
  • Vision loss or blindness

To minimize the risk of these complications and ensure the best possible visual outcomes, patients should:

  1. Attend regular follow-up appointments: The healthcare provider will monitor the patient’s eye health, assess the response to treatment, and adjust the management plan as needed.
  2. Adhere to the prescribed treatment plan: Patients must take medications as directed and complete the full course of treatment, even if their symptoms improve.
  3. Report any new or worsening symptoms: Prompt medical attention can help prevent minor issues from developing into more serious complications.
  4. Protect the eyes from further damage: Patients should wear sunglasses or a wide-brimmed hat when outdoors to protect the eyes from UV radiation, which can exacerbate ocular inflammation.
  5. Maintain good overall health: A healthy lifestyle, including a balanced diet, regular exercise, and stress management, can support the immune system and promote healing.

By working closely with their healthcare provider and taking an active role in their eye health, patients can minimize the risk of long-term complications and preserve their vision.

Chickenpox in the Eye: Special Considerations

Certain patient populations may require additional considerations when it comes to managing chickenpox in the eye. These include:

Pregnant Women

Chickenpox during pregnancy can lead to serious complications for both the mother and the developing fetus, including congenital varicella syndrome[22]. Pregnant women who contract chickenpox or develop ocular complications should:

  • Seek immediate medical attention from an obstetrician and an ophthalmologist.
  • Undergo close monitoring for maternal and fetal complications.
  • Receive appropriate antiviral treatment and supportive care.
  • Plan for a safe delivery and postpartum care.

Immunocompromised Patients

Patients with weakened immune systems due to conditions like HIV/AIDS, cancer, or immunosuppressive medications are at a higher risk of developing severe chickenpox and ocular complications[23]. These patients should:

  • Receive prompt and aggressive antiviral treatment.
  • Undergo close monitoring for systemic and ocular complications.
  • Work with their healthcare provider to optimize their overall health and immune function.
  • Consider prophylactic antiviral therapy if exposed to chickenpox or shingles.

Children

While children are less likely to develop severe ocular complications from chickenpox compared to adults, they can still experience significant discomfort and potential vision problems[24]. Parents and caregivers should:

  • Ensure children receive the recommended varicella vaccine doses.
  • Monitor children for any eye-related symptoms during or after a chickenpox infection.
  • Seek prompt medical attention if ocular symptoms develop.
  • Provide supportive care, such as cool compresses and lubricating eye drops, to alleviate discomfort.
  • Encourage children to avoid rubbing their eyes to prevent further irritation and the spread of infection.

By taking these special considerations into account, healthcare providers can tailor their management strategies to meet the unique needs of these patient populations and ensure the best possible outcomes.

Frequently Asked Questions about Chickenpox in the Eye

Can chickenpox cause permanent eye damage?

Yes, if left untreated or if the ocular complications are severe, chickenpox in the eye can lead to permanent eye damage, including vision loss or blindness[25]. Prompt diagnosis and appropriate treatment are essential to minimize the risk of long-term complications.

Is chickenpox in the eye contagious?

Chickenpox itself is highly contagious and can be transmitted through direct contact with the fluid from chickenpox blisters or through airborne droplets when an infected person coughs or sneezes. However, ocular complications of chickenpox are not contagious in the same way. While it is possible for the varicella-zoster virus to spread from the eye to other parts of the body or to other people through direct contact with eye secretions, this is less common than transmission through skin lesions or respiratory droplets[26].

How long does it take for chickenpox in the eye to heal?

The duration of ocular complications from chickenpox can vary depending on the specific condition and its severity. Mild cases of conjunctivitis or keratitis may resolve within a few days to a couple of weeks with appropriate treatment. More severe conditions, such as uveitis or retinitis, may require longer treatment and recovery periods, ranging from several weeks to months[27]. In some cases, long-term management may be necessary to prevent or treat chronic complications.

Can the varicella vaccine prevent chickenpox in the eye?

Yes, the varicella vaccine is highly effective in preventing chickenpox and its complications, including ocular manifestations. Studies have shown that the vaccine can reduce the risk of chickenpox by up to 90% and the risk of severe complications by up to 95%[28]. However, it is important to note that no vaccine is 100% effective, and breakthrough infections can still occur in vaccinated individuals, although they are usually milder and less likely to lead to complications.

Can shingles cause eye problems similar to chickenpox?

Yes, shingles, which is caused by the reactivation of the dormant varicella-zoster virus in people who have previously had chickenpox, can lead to ocular complications similar to those seen in chickenpox. In fact, shingles involving the eye, known as herpes zoster ophthalmicus, is more common in adults than ocular complications from primary chickenpox infection[29]. Symptoms and management strategies for herpes zoster ophthalmicus are similar to those for chickenpox in the eye, with a focus on antiviral therapy, inflammation control, and prevention of long-term complications.

Conclusion

Chickenpox in the eye is a potentially serious condition that can lead to significant discomfort, vision loss, and long-term complications if not promptly diagnosed and treated. As a medical professional, it is crucial to educate patients about the ocular manifestations of chickenpox, the importance of vaccination and hygiene measures for prevention, and the need for prompt medical attention if eye symptoms develop.

Patients should be aware of the various ocular complications associated with chickenpox, such as conjunctivitis, keratitis, uveitis, and retinitis, and understand the risk factors that may increase their susceptibility to these conditions. By working closely with their healthcare provider and taking an active role in their eye health, patients can minimize the risk of long-term complications and preserve their vision.

Key takeaways for patients:

  1. Chickenpox can affect the eyes, leading to various ocular complications that can cause discomfort, vision loss, and long-term damage if left untreated.
  2. Vaccination is the most effective way to prevent chickenpox and its ocular complications.
  3. Practicing good hygiene can help reduce the risk of contracting or spreading the varicella-zoster virus.
  4. Prompt medical attention is essential if any eye symptoms develop during or after a chickenpox infection.
  5. Regular follow-up care and adherence to the prescribed treatment plan are crucial for minimizing the risk of long-term complications and preserving vision.

By understanding the potential impact of chickenpox on eye health and taking proactive steps to prevent and manage ocular complications, patients can work with their healthcare providers to ensure the best possible outcomes.

References

  1. Centers for Disease Control and Prevention. (2021). Chickenpox (Varicella): Transmission. https://www.cdc.gov/chickenpox/about/transmission.html
  2. Gnann, J. W., Jr. (2002). Varicella-zoster virus: atypical presentations and unusual complications. The Journal of Infectious Diseases, 186 Suppl 1, S91-S98. https://doi.org/10.1086/342963
  3. Ragozzino, M. W., Melton, L. J., 3rd, Kurland, L. T., Chu, C. P., & Perry, H. O. (1982). Population-based study of herpes zoster and its sequelae. Medicine, 61(5), 310-316. https://doi.org/10.1097/00005792-198209000-00003
  4. Liesegang, T. J. (1999). Varicella-zoster virus eye disease. Cornea, 18(5), 511-531. https://doi.org/10.1097/00003226-199909000-00002
  5. Womack, L. W., & Liesegang, T. J. (1983). Complications of herpes zoster ophthalmicus. Archives of Ophthalmology, 101(1), 42-45. https://doi.org/10.1001/archopht.1983.01040010044004
  6. Yawn, B. P., Wollan, P. C., St Sauver, J. L., & Butterfield, L. C. (2013). Herpes zoster eye complications: rates and trends. Mayo Clinic Proceedings, 88(6), 562-570. https://doi.org/10.1016/j.mayocp.2013.03.014
  7. Guess, H. A., Broughton, D. D., Melton, L. J., 3rd, & Kurland, L. T. (1985). Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics, 76(4), 512-517. https://pubmed.ncbi.nlm.nih.gov/3863086/
  8. Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., Seward, J. F., & Yamanishi, K. (2015). Varicella zoster virus infection. Nature Reviews Disease Primers, 1, 15016. https://doi.org/10.1038/nrdp.2015.16
  9. Shaikh, S., & Ta, C. N. (2002). Evaluation and management of herpes zoster ophthalmicus. American Family Physician, 66(9), 1723-1730. https://pubmed.ncbi.nlm.nih.gov/12449270/
  10. Pavan-Langston, D. (1999). Herpes zoster ophthalmicus. Neurology, 45(12 Suppl 8), S50-S51. https://doi.org/10.1212/wnl.45.12_suppl_8.s50
  11. Schmader, K. (1998). Postherpetic neuralgia in immunocompetent elderly people. Vaccine, 16(18), 1768-1770. https://doi.org/10.1016/s0264-410x(98)00137-6
  12. Karbassi, M., Raizman, M. B., & Schuman, J. S. (1992). Herpes zoster ophthalmicus. Survey of Ophthalmology, 36(6), 395-410. https://doi.org/10.1016/S0039-6257(05)80021-9
  13. Colin, J., Prisant, O., Cochener, B., Lescale, O., Rolland, B., & Hoang-Xuan, T. (2000). Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology, 107(8), 1507-1511. https://doi.org/10.1016/s0161-6420(00)00222-0
  14. Marsh, R. J., & Cooper, M. (1993). Ophthalmic zoster: mucous plaque keratitis. The British Journal of Ophthalmology, 77(11), 725-728. https://doi.org/10.1136%2Fbjo.71.10.725
  15. Liesegang, T. J. (2008). Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology, 115(2 Suppl), S3-S12. https://doi.org/10.1016/j.ophtha.2007.10.009
  16. Marin, M., Güris, D., Chaves, S. S., Schmid, S., Seward, J. F., & Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). (2007). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports, 56(RR-4), 1-40. https://pubmed.ncbi.nlm.nih.gov/17585291/
  17. Levin, M. J., Gershon, A. A., Weinberg, A., Song, L. Y., Fentin, T., Nowak, B., & Pediatric AIDS Clinical Trials Group 265 Team. (2006). Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. The Journal of Infectious Diseases, 194(2), 247-255. https://doi.org/10.1086/505149
  18. Wilhelmus, K. R., Gee, L., Hauck, W. W., Kurinij, N., Dawson, C. R., Jones, D. B., Barron, B. A., Kaufman, H. E., Sugar, J., & Hyndiuk, R. A. (1994). Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology, 101(12), 1883-1896. https://doi.org/10.1016/s0161-6420(13)31155-5
  19. Barron, B. A., Gee, L., Hauck, W. W., Kurinij, N., Dawson, C. R., Jones, D. B., Wilhelmus, K. R., Kaufman, H. E., Sugar, J., & Hyndiuk, R. A. (1994). Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology, 101(12), 1871-1882. https://doi.org/10.1016/S0161-6420(13)31155-5
  20. Herbort, C. P., Boer, J. H., Cheng, C. K., Ikeji, F., Khairallah, M., Lightman, S., Neri, P., Nussenblatt, R. B., Okada, A. A., Pleyer, U., & Rao, N. A. (2010). Uveitis associated with varicella virus vaccine. American Journal of Ophthalmology, 149(5), 733-736. https://doi.org/10.1016/j.ajo.2009.12.013
  21. Franco-Paredes, C., Bellehemeur, T., Merchant, A., Sanghi, P., DiazGranados, C., & Rimland, D. (2002). Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS, 16(7), 1045-1049. https://doi.org/10.1097/00002030-200205030-00017
  22. Boussault, P., Boralevi, F., Labbe, L., Sarlangue, J., Taïeb, A., Leaute-Labreze, C., & Maleville, J. (2007). Chronic varicella-zoster skin infection complicating the congenital varicella syndrome. Pediatric Dermatology, 24(4), 429-432. https://doi.org/10.1111/j.1525-1470.2007.00459.x
  23. Arvin, A. M., Moffat, J. F., Sommer, M., Oliver, S., Che, X., Vleck, S., Zerboni, L., & Ku, C. C. (2010). Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Current Topics in Microbiology and Immunology, 342, 189-209. https://doi.org/10.1007/82_2010_29
  24. Siedler, A., & Arndt, U. (2010). Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin, 15(13), 19530. https://doi.org/10.2807/ese.15.13.19530-en
  25. Yawn, B. P., Wollan, P. C., St Sauver, J. L., & Butterfield, L. C. (2013). Herpes zoster eye complications: rates and trends. Mayo Clinic Proceedings, 88(6), 562-570. https://doi.org/10.1016/j.mayocp.2013.03.014
  26. Pavan-Langston, D. (2000). Herpes zoster antivirals and pain management. Ophthalmology, 107(S1), S17-S21. https://doi.org/10.1016/j.ophtha.2007.10.012
  27. Cobo, L. M., Foulks, G. N., Liesegang, T., Lass, J., Sutphin, J. E., Wilhelmus, K., Jones, D. B., Chapman, S., Segreti, A. C., & Kaufman, H. E. (1986). Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology, 93(6), 763-770. https://doi.org/10.1016/s0161-6420(86)33678-9
  28. Seward, J. F., Marin, M., & Vázquez, M. (2008). Varicella vaccine effectiveness in the US vaccination program: a review. The Journal of Infectious Diseases, 197 Suppl 2, S82-S89. https://doi.org/10.1086/522145
  29. Opstelten, W., Zaal, M. J., Eekhof, J. A., Rietveld, A. C., & van Wijck, A.J. (2005). Managing ophthalmic herpes zoster in primary care. BMJ (Clinical Research Ed.), 331(7509), 147-151. https://doi.org/10.1136/bmj.331.7509.147
5/5 - (1 vote)


Image
Image

MIRARI®
Cold Plasma System

The world's first handheld cold plasma device

Learn More


Made in USA

Image